The Efficacy and Safety of Different Combination Regimens of Inetetamab in First-line Treatment of HER2 Positive Metastatic Breast Cancer
Latest Information Update: 21 Oct 2024
At a glance
- Drugs Trastuzumab (Primary) ; Pertuzumab; Pyrotinib
- Indications HER2 positive breast cancer
- Focus Therapeutic Use
- Acronyms IFANS
- 21 Oct 2024 New trial record